Arizona backtracks on Purdue opioid settlement

Oct. 8, 2019

Arizona is the first state to switch its support in a proposed settlement with Purdu Pharma's opioid case. Last month the drugmaker reached a deal with 24 states and the local governments where it was facing more than 2,600 lawsuits. 

The proposed nationwide opioid settlement with Purdue is estimated to be worth more than $10 billion. In a court filing, the state claims that Purdue is attempting to "undermine material terms of the deal." Arizona's filing did not contain more information on why it is now walking back its support.

Purdue and its owners are charged with a leading proponent in the opioid crisis through its aggressive marketing and misleading patients of overdose risks.

Read the Reuters report